Disparate spinal and supraspinal opioid antinociceptive responses in β-endorphin-deficient mutant mice (original) (raw)

ÐThe role of endogenous opioid systems in the analgesic response to exogenous opiates remains controversial. We previously reported that mice lacking the peptide neurotransmitter b-endorphin, although unable to produce opioid-mediated stressinduced antinociception, nevertheless displayed intact antinociception after systemic administration of the exogenous opiate morphine. Morphine administered by a peripheral route can activate opioid receptors in both the spinal cord and brain. However, b-endorphin neuronal projections are con®ned predominantly to supraspinal nociceptive nuclei. Therefore, we questioned whether the absence of b-endorphin would differentially affect antinociceptive responses depending on the route of opiate administration. Time-and dose±response curves were obtained in b-endorphin-de®cient and matched wild-type C57BL/6 congenic control mice using the tail-immersion/withdrawal assay. Null mutant mice were found to be more sensitive to supraspinal (i.c.v.) injection of the m-opioid receptor-selective agonists, morphine and d-Ala 2-MePhe 4-Gly-ol 5 enkephalin. In contrast, the mutant mice were less sensitive to spinal (i.t.) injection of these same drugs. Quantitative receptor autoradiography revealed no differences between genotypes in the density of m, d, or k opioid receptor binding sites in either the spinal cord or pain-relevant supraspinal areas. Thus we report that the absence of a putative endogenous ligand for the m-opioid receptor results in opposite changes in morphine sensitivity between discrete areas of the nervous system, which are not simply caused by changes in opioid receptor expression.